~~<i id='D20F30FB76'><strike id='D20F30FB76'><tt id='D20F30FB76'><pre id='D20F30FB76'></pre></tt></strike></i>~~

Home» knowledge» focus

focus

author：fashion 2025-10-06 08:50:12 Page View：9

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： NYC plans to house migrants on an island in the East River
Next article： In Memoriam: Notable people who died in 2023

Wikipedia

Apple is now the first public company to be valued at $3 trillion

6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

Vertigo drug brings hope for rare neuron disorder, Niemann

ThecerebellumofamousebrainaffectedbyNiemann-PickTypeC.EuniceKennedyShriverNationalInstituteofChildHe

United colonoscopy coverage change 'may cost lives,' doctors say

AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

Trump Jan. 6 attorney John Lauro is ex

9:45SplitimagefeaturingattorneyforformerPresidentDonaldTrump,JohnLauro,speakstoABC'sGeorgeStephanopo